O'Keefe Stevens Advisory’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $327K | Hold |
2,544
| – | – | 0.07% | 65 |
|
|
2026
Q1 | $306K | Sell |
2,544
-25
| -1% | -$2.89K | 0.08% | 63 |
|
|
2025
Q4 | $270K | Buy |
2,569
+25
| +1% | +$2.35K | 0.07% | 60 |
|
|
2025
Q3 | $213K | Hold |
2,544
| – | – | 0.06% | 64 |
|
|
2025
Q2 | $201K | Hold |
2,544
| – | – | 0.06% | 67 |
|
|
2025
Q1 | $228K | Sell |
2,544
-1,172
| -32% | -$109K | 0.07% | 66 |
|
|
2024
Q4 | $370K | Hold |
3,716
| – | – | 0.11% | 56 |
|
|
2024
Q3 | $422K | Hold |
3,716
| – | – | 0.13% | 53 |
|
|
2024
Q2 | $460K | Hold |
3,716
| – | – | 0.15% | 37 |
|
|
2024
Q1 | $490K | Hold |
3,716
| – | – | 0.16% | 34 |
|
|
2023
Q4 | $405K | Hold |
3,716
| – | – | 0.16% | 35 |
|
|
2023
Q3 | $383K | Hold |
3,716
| – | – | 0.17% | 30 |
|
|
2023
Q2 | $429K | Hold |
3,716
| – | – | 0.18% | 30 |
|
|
2023
Q1 | $395K | Sell |
3,716
-140
| -4% | -$15.1K | 0.2% | 29 |
|
|
2022
Q4 | $428K | Buy |
3,856
+100
| +3% | +$10.2K | 0.25% | 28 |
|
|
2022
Q3 | $323K | Hold |
3,756
| – | – | 0.22% | 28 |
|
|
2022
Q2 | $342K | Buy |
3,756
+40
| +1% | +$3.55K | 0.21% | 29 |
|
|
2022
Q1 | $305K | Hold |
3,716
| – | – | 0.15% | 33 |
|
|
2021
Q4 | $285K | Hold |
3,716
| – | – | 0.13% | 35 |
|
|
2021
Q3 | $279K | Hold |
3,716
| – | – | 0.15% | 35 |
|
|
2021
Q2 | $289K | Sell |
3,716
-178
| -5% | -$13.2K | 0.15% | 34 |
|
|
2021
Q1 | $283K | Hold |
3,894
| – | – | 0.18% | 32 |
|
|
2020
Q4 | $304K | Hold |
3,894
| – | – | 0.21% | 34 |
|
|
2020
Q3 | $308K | Buy |
3,894
+68
| +2% | +$5.33K | 0.24% | 32 |
|
|
2020
Q2 | $282K | Buy |
+3,826
| New | +$288K | 0.24% | 32 |
|
|
2019
Q4 | $346K | Hold |
3,957
| – | – | 0.26% | 33 |
|
|
2019
Q3 | $318K | Buy |
3,957
+263
| +7% | +$21.1K | 0.24% | 35 |
|
|
2019
Q2 | $296K | Buy |
3,694
+209
| +6% | +$16K | 0.22% | 36 |
|
|
2019
Q1 | $277K | Hold |
3,485
| – | – | 0.22% | 34 |
|
|
2018
Q4 | $254K | Hold |
3,485
| – | – | 0.23% | 36 |
|
|
2018
Q3 | $236K | Hold |
3,485
| – | – | 0.17% | 39 |
|
|
2018
Q2 | $202K | Buy |
+3,485
| New | +$197K | 0.16% | 38 |
|
|
2018
Q1 | – | Sell |
-3,733
| Closed | -$200K | – | 47 |
|
|
2017
Q4 | $200K | Buy |
+3,733
| New | +$207K | 0.18% | 44 |
|
Other funds holding MRK
LMFP
ATO
QP
O'Keefe Stevens Advisory's MRK Position: Q2 2026 in Review
O'Keefe Stevens Advisory held its Merck (MRK) position steady in Q2 2026 at 2,544 shares worth $327K. The position accounts for 0.07% of the portfolio, ranked #65.
O'Keefe Stevens Advisory first reported a position in MRK in Q4 2017 and has held it in 33 quarters since. The position peaked at $490K in Q1 2024. 1,246 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- O'Keefe Stevens Advisory held 2,544 shares of Merck worth $327K as of Q2 2026.
- O'Keefe Stevens Advisory left its Merck share count unchanged in Q2 2026.
- Merck made up 0.07% of O'Keefe Stevens Advisory's portfolio in Q2 2026, its #65 holding.
- O'Keefe Stevens Advisory first reported a position in Merck in Q4 2017 and has held it in 33 quarters since.
- O'Keefe Stevens Advisory's Merck position peaked at $490K in Q1 2024.
- 1,246 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on O'Keefe Stevens Advisory's 13F filing for Q2 2026, filed 13 Jul 2026.